M&A Deal Summary

Porsolt Acquires Fluofarma SA

On December 10, 2015, Porsolt acquired life science company Fluofarma SA

Acquisition Highlights
  • This is Porsolt’s 1st transaction in the Life Science sector.
  • This is Porsolt’s 1st transaction in France.

M&A Deal Summary

Date 2015-12-10
Target Fluofarma SA
Sector Life Science
Buyer(s) Porsolt
Deal Type Add-on Acquisition

Target

Fluofarma SA

Pessac, France
Fluofarma SA is specializes in providing tailored services in cell biology and high content analysis, an approach highly solicited in association with predictive tools and cell-based models, thereby fulfilling pharmaceutical industry requirements to optimize the drug discovery pipeline.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Porsolt

Le Genest-Saint-Isle, France

Category Company
Founded 1984
Sector Life Science
Employees100
Revenue 11M EUR (2023)
DESCRIPTION

Porsolt is a global preclinical Contract Research Organization (CRO) that works with pharmaceutical and biotechnology companies, academic institutes, and not-for-profit organizations, offering specialized preclinical testing services across many disease areas, physiological systems, and processes. It provides a range of services including drug discovery, screening, as well as efficacy and pharmacological safety testing, using both standardized and innovative techniques in full compliance with GLP (ICH S7). Porsolt was founded in 1984 and is based in Le Genest-Saint-Isle, France.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2015 M&A 1 of 1